# Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

> **NCT00033332** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** pamidronate disodium
- **DRUG:** thalidomide
- **DRUG:** zoledronic acid

## Key facts

- **NCT ID:** NCT00033332
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2006-03
- **Final completion:** 2006-06
- **Target enrollment:** — (—)
- **Last updated:** 2014-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00033332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00033332, "Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma". Retrieved via AI Analytics 2026-06-20 from https://api.ai-analytics.org/clinical/NCT00033332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*